Zhengye Biotechnology Holding (ZYBT) Prepaid Assets (2024 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Prepaid Assets of $3.6 million for Q4 2025, up 889.89% year-over-year from $365580.5 in Q4 2024, and up 0.78% quarter-over-quarter from $3.6 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Prepaid Assets (2024 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Prepaid Assets for 2 consecutive years, with $3.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 889.89% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $3.6 million (up 889.89% YoY), while the FY2025 annual figure was $3.7 million, up 903.88% from the prior year.
- Prepaid Assets rose to $3.6 million in Q4 2025 per ZYBT's latest filing, from $3.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.6 million in Q4 2025 and bottomed at $365580.5 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Zhengye Biotechnology Holding | 85.40 Mn | 78.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.62 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Dec 31, 2024 | 365,580.48 |